Strategic
Partnerships
JCA Global works closely with scientific, biotechnology, and integrative medicine partners to ensure the responsible adoption of emerging and traditional healing modalities, with integrity, education, and long-term impact at the center of every collaboration.

Novatrail, Inc.
Cell-Free Regenerative Science Developed in Japan
JCA Global maintains a strategic partnership with Novatrail, Inc., a biotechnology company advancing cell-free regenerative science developed in Japan. Through this collaboration, JCA Global serves as a trusted bridge between Novatrail's scientific innovation and U.S. clinical and wellness markets.
Jaye Camposanto Andaya holds dual roles as Novatrail's Global Ambassador and U.S. Clinical Liaison — providing educational outreach, strategic market guidance, and direct relationship support with U.S.-based clinicians, practitioners, and distribution partners.
This partnership is grounded in shared values: scientific rigor, ethical communication, patient-centered outcomes, and a commitment to advancing regenerative medicine responsibly across borders.
How JCA Global Partners
Cell-Free Regenerative Technology
Supporting the responsible introduction of Japan's leading cell-free regenerative biotechnology to U.S. clinical and wellness markets through education, relationship-building, and ethical communication.
Cross-Border Collaboration
Bridging scientific innovation between international markets and the United States — facilitating dialogue, strategic alignment, and mutual understanding across cultures and regulatory environments.
Education & Scientific Communication
Developing clear, credible, and accessible educational frameworks for practitioners, patients, and industry stakeholders navigating the evolving landscape of regenerative medicine.
Strategic Partnership Development
Cultivating long-term relationships between regenerative science innovators and aligned clinical and wellness leaders in the United States, grounded in integrity and shared values.
Preparing a U.S. market entry? Explore AdvisoryIntegrative & Traditional Medicine Collaborations
Healing traditions such as Traditional Thai Medicine, Ayurveda, Traditional Chinese Medicine, and Filipino Hilot carry generations of knowledge. JCA Global partners with credentialed practitioners and organizations from these traditions to build credibility, education, and responsible pathways into U.S. clinical and wellness markets, while honoring the integrity of each tradition.
Who We Work With
Licensed and credentialed traditional medicine practitioners
Schools and training institutions
Integrative clinics, retreats, and wellness destinations
Traditional wellness brands preparing for U.S. entry
Ways to Partner
Collaboration
Co-created education, ARAW Science webinars, content partnerships, and cross-referral relationships.
Strategic Partnership
Joint programs, retreat and wellness-destination programming, and practitioner education initiatives.
Formal Advisory
Retained engagements for U.S. market entry, clinical positioning, credibility-building, and compliance readiness.
Explore AdvisoryAlignment Standards
Verified Credentials
Licensure or recognized certification in the practitioner's home country.
Responsible Claims
No disease-treatment claims. Education grounded in available evidence.
Cultural Integrity
Traditions represented accurately and respectfully, with credit to their origins.
Patient-Centered Ethics
Safety, informed choice, and appropriate scope of practice.
Transparency
Clear disclosure of roles, relationships, and compensation.
JCA Global collaborations are educational and strategic in nature. JCA Global does not endorse specific treatments, products, or practitioners, and partnership does not constitute clinical validation.
"The future of regenerative medicine, longevity and holistic wellness will be built through trust — across borders, disciplines, and cultures. Partnership is not a strategy. It is the foundation."— Jaye Camposanto Andaya, PA
Exploring a Partnership?
JCA Global welcomes conversations with biotech companies, researchers, clinicians, traditional and integrative medicine practitioners, investors, and global health innovators aligned with responsible innovation in regenerative and integrative medicine.